Log In
Print
BCIQ
Print
Print this Print this
 

EC1719

  Manage Alerts
Collapse Summary General Information
Company Endocyte Inc.
DescriptionPSMA-tubulysin
Molecular Target Prostate-specific membrane antigen (PSMA) (FOLH1) (GCPII)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today